Catalyst
Slingshot members are tracking this event:
Depomed Releases Lazanda 300 mcg Dose for Treatment of Breakthrough Cancer Pain
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| DEPO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 07, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Transmucosal Immediate Release Fentanyl, Lazanda, Btpc, Cancer Pain
